As Alnylam Pharmaceuticals (ALNY) Stock Value Declined, 12 West Capital Management LP Lifted Stake; West Family Investments Has Increased Its Humana (HUM) Stake by $2.62 Million; Market Valuation Rose

Humana Inc. (NYSE:HUM) Logo

West Family Investments Inc increased its stake in Humana Inc (HUM) by 9900% based on its latest 2019Q2 regulatory filing with the SEC. West Family Investments Inc bought 9,900 shares as the company’s stock rose 20.55% . The institutional investor held 10,000 shares of the medical specialities company at the end of 2019Q2, valued at $2.65 million, up from 100 at the end of the previous reported quarter. West Family Investments Inc who had been investing in Humana Inc for a number of months, seems to be bullish on the $45.66B market cap company. The stock increased 0.87% or $2.97 during the last trading session, reaching $344.81. About 537,327 shares traded. Humana Inc. (NYSE:HUM) has declined 5.19% since December 4, 2018 and is downtrending. It has underperformed by 5.19% the S&P500. Some Historical HUM News: 29/03/2018 – Carl O’Donnell: Walmart discussing closer ties with Humana, including possible acquisition; 29/03/2018 – Greg Roumeliotis: Walmart discussing closer ties with Humana, including possible acquisition; 08/05/2018 – Humana Partners with Feeding America® to Address Food Insecurity Among Veterans Across the Country; 29/03/2018 – Dana Mattioli: Scoop: Walmart has made a takeover approach to Humana. W/ @SarahNassauer; 29/03/2018 – WALMART IS SAID TO BE IN EARLY DEAL TALKS WITH HUMANA: DJ/CNBC; 02/04/2018 – Deals of the day-Mergers and acquisitions; 23/05/2018 – Humana Teams up with Jefferson Regional Medical Center and Arkansas Department of Health to Promote Hypertension Team-Based Car; 02/05/2018 – Humana 1Q Net $707M; 02/05/2018 – Humana Raises 2018 View To Adj EPS $13.70-Adj EPS $14.10; 02/05/2018 – Humana 1Q EPS $3.53

12 West Capital Management Lp increased its stake in Alnylam Pharmaceuticals Inc (ALNY) by 179.47% based on its latest 2019Q2 regulatory filing with the SEC. 12 West Capital Management Lp bought 472,000 shares as the company’s stock declined 6.55% . The hedge fund held 735,000 shares of the health care company at the end of 2019Q2, valued at $53.33M, up from 263,000 at the end of the previous reported quarter. 12 West Capital Management Lp who had been investing in Alnylam Pharmaceuticals Inc for a number of months, seems to be bullish on the $13.65 billion market cap company. The stock increased 0.08% or $0.1 during the last trading session, reaching $122.47. About 527,139 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has declined 19.85% since December 4, 2018 and is downtrending. It has underperformed by 19.85% the S&P500. Some Historical ALNY News: 08/05/2018 – Alnylam Reports Preclinical Data Demonstrating Central Nervous System (CNS) Delivery of RNAi Therapeutics; 07/05/2018 – MDCO: INCLISIRAN DATA SHOWS CUTS IN SUBTYPES OF BAD CHOLESTEROL; 20/04/2018 – Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade Secret Misappropriation and Other Pending Litigation; 03/05/2018 – ALNYLAM PHARMACEUTICALS INC – CO AND FDA HAVE ALIGNED ON A STUDY SIZE OF APPROXIMATELY 25 PATIENTS WITH PH1; 10/05/2018 – Bloomberg Baystate Business: Alnylam, Airbnb, Uber; 20/04/2018 – DICERNA PHARMACEUTICALS – SETTLEMENT EXCLUDES ANY AMOUNTS RECEIVED BY DICERNA FROM ITS EXISTING COLLABORATION WITH BOEHRINGER-INGELHEIM; 03/05/2018 – ALNYLAM 1Q ADJ LOSS/SHR $1.22; 03/05/2018 – ALNYLAM PHARMACEUTICALS INC – COMPANY INTENDS TO INITIATE LUMASIRAN PHASE 3 STUDY IN MID-2018, WITH TOPLINE RESULTS EXPECTED IN 2019; 20/04/2018 – Alnylam: Dicerna to Be Restricted in Its Development of Certain Therapeutics for 18 Mos to Four Years; 14/03/2018 – Alnylam to Report New Clinical Results From the APOLLO Phase 3 Study of Patisiran at the 16th Intl Symposium on Amyloidosis

Investors sentiment increased to 1.96 in Q2 2019. Its up 0.69, from 1.27 in 2019Q1. It increased, as 20 investors sold ALNY shares while 47 reduced holdings. 36 funds opened positions while 95 raised stakes. 100.15 million shares or 7.28% more from 93.35 million shares in 2019Q1 were reported. Fukoku Mutual Life Insur Co invested in 0.01% or 800 shares. Spark Investment Mngmt Limited Co holds 0.23% or 46,700 shares in its portfolio. Apg Asset Management Nv stated it has 32,800 shares. Amundi Pioneer Asset Mngmt has invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Sumitomo Mitsui Tru Holdings Incorporated accumulated 347,979 shares. Hall Laurie J Trustee holds 0.14% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) or 3,800 shares. Tarbox Family Office owns 20 shares. Utah Retirement holds 19,572 shares or 0.03% of its portfolio. Employees Retirement Association Of Colorado holds 13,797 shares or 0.01% of its portfolio. Products Ltd Company reported 138,800 shares stake. Barclays Public Limited accumulated 65,893 shares or 0% of the stock. Loring Wolcott Coolidge Fiduciary Advsr Llp Ma owns 2,025 shares. Principal Finance, a Iowa-based fund reported 28,567 shares. Bnp Paribas Arbitrage Sa owns 47,955 shares. Citadel Limited Liability Corporation holds 966,044 shares or 0.03% of its portfolio.

More notable recent Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) news were published by: Nasdaq.com which released: “You Can Hear the Gears Grinding at Avis Budget – Nasdaq” on November 10, 2019, also Finance.Yahoo.com with their article: “The Daily Biotech Pulse: Endo’s Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data – Yahoo Finance” published on November 20, 2019, Benzinga.com published: “Stocks That Hit 52-Week Highs On Tuesday – Benzinga” on November 19, 2019. More interesting news about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) were released by: Nasdaq.com and their article: “Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher? – Nasdaq” published on October 24, 2019 as well as Nasdaq.com‘s news article titled: “U.S. STOCKS ON THE MOVE-General Electric, Cymabay, TD Ameritrade, Uber – Nasdaq” with publication date: November 25, 2019.

More notable recent Humana Inc. (NYSE:HUM) news were published by: Businesswire.com which released: “Humana Honored for Hispanic Inclusion Efforts – Business Wire” on November 25, 2019, also Forbes.com with their article: “Why Humana’s Stock Had A Strong Run In November – Forbes” published on December 02, 2019, Patch.com published: “Mountain View Medical Group and Humana Sign In-Network Agreement – Patch.com” on December 03, 2019. More interesting news about Humana Inc. (NYSE:HUM) were released by: Investorplace.com and their article: “5 Top Stock Trades for Thursday: UBER, MTCH, KL – Investorplace.com” published on November 06, 2019 as well as Finance.Yahoo.com‘s news article titled: “7 Stocks the Vanguard Health Care Fund Keeps Buying – Yahoo Finance” with publication date: November 07, 2019.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.